The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome
Open accessAbstract
Glucocorticoids are stress hormones that modulate a large number of physiological actions involved in metabolic, inflammatory, cardiovascular and behavioral processes. The molecular mechanisms and the physiological effects of glucocorticoids have been extensively studied. However, the involvement of glucocorticoid action in the etiology of the Metabolic Syndrome has not been well appreciated. Recently, accumulating clinical evidence and animal genetics studies have attracted growing interest in the role of glucocorticoid action in obesity and insulin resistance. This review will discuss the metabolic effects in the context of glucocorticoid metabolism and establish the association of glucocorticoid action with the features of the Metabolic Syndrome, especially obesity and insulin resistance. Special discussions will be focused on corticosteroid-binding globulin and 11β-hydroxysteroid dehydrogenase type 1, two proteins that mediate glucocorticoid action and have been implicated in the Metabolic Syndrome. Due to the complexities of the glucocorticoid biology and the Metabolic Syndrome and limited space, this review is only intended to provide a general link between the two areas with broad rather than in-depth discussions of clinical, pharmacological and genetic findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“Mice with adipose-specific overexpression of the rat 11β-HSD1 had increased adipose levels of corticosterone and acquired features of the Metabolic Syndrome: diet-induced visceral obesity, insulin resistance, hyperlipidemia and hyperphagia [151].”
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,568
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 1×
“Since liver fat appears to be involved in the negative regulation of hepatic insulin sensitivity [92] and is associated with certain features of the Metabolic Syndrome independent of visceral fat mass [93-96], hepatic fat accumulation promoted by GCs is likely to contribute to the pathophysiology of the Metabolic Synd…”
Diamond, M. I., Miner, J. N., Yoshinaga, S. K., & Yamamoto, K. R. (1990) · Science · doi:10.1126/science.2119054 · Cited by 1,292
DUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238 · cited 1×
“Plasma cortisone is largely in the free unbound form but approximately 6% cortisol is bound to albumin and 90% is bound to corticosteroidbinding globulin (CBG), a protein synthesized in liver and secreted in blood [26,27].”
Ray, A., & Prefontaine, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.752 · Cited by 1,064
Adverse effects of antiretroviral therapy
Carr, A., & Cooper, D. A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02854-3 · Cited by 1,057
Mechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052 · cited 1×
“Since hepatic gluconeogenesis in diabetics is increased [175], inhibition of hepatic GR action is expected for glucose lowering in diabetics.”
Molecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889
Rosmond, R., Dallman, M. F., & Björntorp, P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4843 · Cited by 871
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753 · cited 1×
“It is important to note that 11β-HSD1 activity is higher in omental fat and subject to stimulation [139].”
Jantzen, H.-M., Strähle, U., Gloss, B., Stewart, F., Schmid, W., Boshart, M., Miksicek, R., & Schütz, G. (1987) · Cell · doi:10.1016/0092-8674(87)90752-5 · Cited by 724
Tissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity
Rask, E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1418 · Cited by 655
Hauner, H., Entenmann, G., Wabitsch, M., Gaillard, D., Ailhaud, G., Negrel, R., & Pfeiffer, E. F. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114345 · Cited by 623
Nissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559
Morton, N. M., Paterson, J. M., Masuzaki, H., Holmes, M. C., Staels, B., Fievet, C., Walker, B. R., Flier, J. S., Mullins, J. J., & Seckl, J. R. (2004) · Diabetes · doi:10.2337/diabetes.53.4.931 · Cited by 512
Negative Regulation by Glucocorticoids Through Interference with a cAMP Responsive Enhancer
Akerblom, I. E., Slater, E. P., Beato, M., Baxter, J. D., & Mellon, P. L. (1988) · Science · doi:10.1126/science.2838908 · Cited by 481
Regulation of Expression of ob mRNA and Protein by Glucocorticoids and cAMP
Slieker, L. J., Sloop, K. W., Surface, P. L., Kriauciunas, A., LaQuier, F., Manetta, J., Bue-Valleskey, J., & Stephens, T. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5301 · Cited by 479
Cortisol secretion in relation to body fat distribution in obese premenopausal women
Mårin, P., Darin, N., Amemiya, T., Andersson, B., Jern, S., & Björntorp, P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90171-6 · Cited by 458
Sakai, D. D., Helms, S., Carlstedt-Duke, J., Gustafsson, J. A., Rottman, F. M., & Yamamoto, K. R. (1988) · Genes & Development · doi:10.1101/gad.2.9.1144 · Cited by 455
Morton, N. M., Holmes, M. C., Fiévet, C., Staels, B., Tailleux, A., Mullins, J. J., & Seckl, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103676200 · Cited by 439
Tannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Masuzaki, H., Yamamoto, H., Kenyon, C. J., Elmquist, J. K., Morton, N. M., Paterson, J. M., Shinyama, H., Sharp, M. G. F., Fleming, S., Mullins, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17845 · Cited by 434 · cited 1×
“The transgenic mice also developed hypertension, at least in part due to the increased adipose expression of angiotensinogen and the consequent activation of the renninangiotensin system (RAS) [152].”
Paterson, J. M., Morton, N. M., Fievet, C., Kenyon, C. J., Holmes, M. C., Staels, B., Seckl, J. R., & Mullins, J. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305524101 · Cited by 431
Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S., Kasahara, T., & Matsushima, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36831-x · Cited by 424
Hormone binding globulins undergo serpin conformational change in inflammation
Pemberton, P. A., Stein, P. E., Pepys, M. B., Potter, J. M., & Carrell, R. W. (1988) · Nature · doi:10.1038/336257a0 · Cited by 423
Lambillotte, C., Gilon, P., & Henquin, J. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119175 · Cited by 419 · cited 1×
“GCs inhibit insulin secretion by the pancreatic β cells in animals and perturb high-frequency insulin release in the fasting state in human [109,110].”
Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5538 · Cited by 398
Syndrome X and Mortality: A Population-based Study
Trevisan, M., Liu, J., Bahsas, F. B., Menotti, A., & for the Risk Factor and Life Expectancy Research Group (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009572 · Cited by 388
Rask, E., Walker, B. R., Söderberg, S., Livingstone, D. E. W., Eliasson, M., Johnson, O., Andrew, R., & Olsson, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8661 · Cited by 386
Cortisol Effects on Body Mass, Blood Pressure, and Cholesterol in the General Population
Fraser, R., Ingram, M. C., Anderson, N. H., Morrison, C., Davies, E., & Connell, J. M. C. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1364 · Cited by 370
Pasquali, R., Cantobelli, S., Casimirri, F., Capelli, M., Bortoluzzi, L., Flamia, R., Labate, A. M., & Barbara, L. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.2.8393881 · Cited by 366
Livingstone, D. E. W., Jones, G. C., Smith, K., Jamieson, P. M., Andrew, R., Kenyon, C. J., & Walker, B. R. (2000) · Endocrinology · doi:10.1210/endo.141.2.7297 · Cited by 347
Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene.
Drouin, J., Sun, Y. L., Chamberland, M., Gauthier, Y., De Léan, A., Nemer, M., & Schmidt, T. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05640.x · Cited by 323
Reynolds, R. M., Walker, B. R., Syddall, H. E., Andrew, R., Wood, P. J., Whorwood, C. B., & Phillips, D. I. W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7145 · Cited by 322
Becker, P. B., Gloss, B., Schmid, W., Strähle, U., & Schütz, G. (1986) · Nature · doi:10.1038/324686a0 · Cited by 313
HAUNER, H., SCHMID, P., & PFEIFFER, E. F. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-4-832 · Cited by 308
Imai, E., Stromstedt, P. E., Quinn, P. G., Carlstedt-Duke, J., Gustafsson, J. A., & Granner, D. K. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4712 · Cited by 299
Reaven, G. M. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.195 · Cited by 287
Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2
Kotelevtsev, Y., Brown, R. W., Fleming, S., Kenyon, C., Edwards, C. R. W., Seckl, J. R., & Mullins, J. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4445 · Cited by 284
Olefsky, J. M. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108231 · Cited by 277
DIMITRIADIS, G., LEIGHTON, B., PARRY-BILLINGS, M., SASSON, S., YOUNG, M., KRAUSE, U., BEVAN, S., PIVA, T., WEGENER, G., & NEWSHOLME, E. A. (1997) · Biochemical Journal · doi:10.1042/bj3210707 · Cited by 266
Andrews, R. C., Rooyackers, O., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021194 · Cited by 266
A Role for Corticosteroid-Binding Globulin in Delivery of Cortisol to Activated Neutrophils*
HAMMOND, G. L., SMITH, C. L., PATERSON, N. A. M., & SIBBALD, W. J. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-1-34 · Cited by 265
Alberts, P., Nilsson, C., Selén, G., Engblom, L. O. M., Edling, N. H. M., Norling, S., Klingström, G., Larsson, C., Forsgren, M., Ashkzari, M., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0344 · Cited by 263
Visceral fat and liver fat are independent predictors of metabolic risk factors in men
Nguyen-Duy, T.-B., Nichaman, M. Z., Church, T. S., Blair, S. N., & Ross, R. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00442.2002 · Cited by 261
P., A., L., E., N., E., M., F., G., K., C., L., Y., R.-N., B., Ö., & L., A. (2002) · Diabetologia · doi:10.1007/s00125-002-0959-6 · Cited by 259
Sandeep, T. C., Yau, J. L. W., MacLullich, A. M. J., Noble, J., Deary, I. J., Walker, B. R., & Seckl, J. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306996101 · Cited by 247
Paulmyer-Lacroix, O., Boullu, S., Oliver, C., Alessi, M.-C., & Grino, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8614 · Cited by 241
Glucocorticoids inhibit the production of IL 6 from monocytes, endothelial cells and fibroblasts
Waage, A., Slupphaug, G., & Shalaby, R. (1990) · European Journal of Immunology · doi:10.1002/eji.1830201112 · Cited by 231
Wake, D. J., Rask, E., Livingstone, D. E. W., Söderberg, S., Olsson, T., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030286 · Cited by 231
Lindsay, R. S., Wake, D. J., Nair, S., Bunt, J., Livingstone, D. E. W., Permana, P. A., Tataranni, P. A., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030017 · Cited by 225 · cited 1×
“The association of adipose 11β-HSD1 with BMI and other features of the Metabolic Syndrome was also found in populations of different ethnic backgrounds [137].”
Malkoski, S. P. (1999) · Molecular Endocrinology · doi:10.1210/me.13.10.1629 · Cited by 225
Barf, T., Vallgårda, J., Emond, R., Häggström, C., Kurz, G., Nygren, A., Larwood, V., Mosialou, E., Axelsson, K., Olsson, R., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025530f · Cited by 211
Harris, H. J., Kotelevtsev, Y., Mullins, J. J., Seckl, J. R., & Holmes, M. C. (2001) · Endocrinology · doi:10.1210/endo.142.1.7887 · Cited by 209
Kannisto, K., Pietiläinen, K. H., Ehrenborg, E., Rissanen, A., Kaprio, J., Hamsten, A., & Yki-Järvinen, H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0153 · Cited by 205
Ljung, T., Andersson, B., Bengtsson, B., Björntorp, P., & Mårin, P. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00546.x · Cited by 200
Danesch, U., Gloss, B., Schmid, W., Schütz, G., Schüle, R., & Renkawitz, R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04800.x · Cited by 192
Odermatt, A., Arnold, P., Stauffer, A., Frey, B. M., & Frey, F. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28762 · Cited by 190 · cited 1×
“11βHSD1 has one short N-terminal transmembrane region with the catalytic domain protruding into the ER lumen; in contrast, the N-terminus of 11β-HSD2 is lumenal with the catalytic domain facing the cytoplasm [123-125].”
Yau, J. L. W., Noble, J., Kenyon, C. J., Hibberd, C., Kotelevtsev, Y., Mullins, J. J., & Seckl, J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071562698 · Cited by 190
Tomlinson, J. W., Sinha, B., Bujalska, I., Hewison, M., & Stewart, P. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020687 · Cited by 187
Effect of adrenalectomy and glucocorticoid replacement on development of obesity
Freedman, M. R., Horwitz, B. A., & Stern, J. S. (1986) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1986.250.4.r595 · Cited by 183
Increased Glucocorticoid Activity in Men With Cardiovascular Risk Factors
Walker, B. R., Phillips, D. I. W., Noon, J. P., Panarelli, M., Andrew, R., Edwards, H. V., Holton, D. W., Seckl, J. R., Webb, D. J., & Watt, G. C. M. (1998) · Hypertension · doi:10.1161/01.hyp.31.4.891 · Cited by 178
Walker, B. R., Campbell, J. C., Fraser, R., Stewart, P. M., & Edwards, C. R. W. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01478.x · Cited by 170
Pseudo‐Cushing's Syndrome in Human Immunodeficiency Virus– Infected Patients
Miller, K. K., Sentochnik, P. A. D., Doweiko, J., Samore, M., Basgoz, & Grinspoon, S. K. (1998) · Clinical Infectious Diseases · doi:10.1086/514638 · Cited by 170
Argaud, D., Zhang, Q., Pan, W., Maitra, S., Pilkis, S. J., & Lange, A. J. (1996) · Diabetes · doi:10.2337/diab.45.11.1563 · Cited by 168 · cited 1×
“GCs also induce the hepatic gluconeogenic pathway via the activation of GR, which stimulates the expression of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), the rate-limiting enzymes in gluconeogenesis [97,98].”
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Strömstedt, P. E., Poellinger, L., Gustafsson, J. A., & Carlstedt-Duke, J. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3379 · Cited by 164
Liver‐Fat Accumulation and Insulin Resistance in Obese Women with Previous Gestational Diabetes
Tiikkainen, M., Tamminen, M., Häkkinen, A., Bergholm, R., Vehkavaara, S., Halavaara, J., Teramo, K., Rissanen, A., & Yki‐Järvinen, H. (2002) · Obesity Research · doi:10.1038/oby.2002.118 · Cited by 162
Valsamakis, G., Anwar, A., Tomlinson, J. W., Shackleton, C. H. L., McTernan, P. G., Chetty, R., Wood, P. J., Banerjee, A. K., Holder, G., Barnett, A. H., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032240 · Cited by 160
Mordacq, J. C., & Linzer, D. I. H. (1989) · Genes & Development · doi:10.1101/gad.3.6.760 · Cited by 154
Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma
Covar, R. A., Leung, D. Y. M., McCormick, D., Steelman, J., Zeitler, P. S., & Spahn, J. D. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.109830 · Cited by 147
Filipovský, J., Ducimetière, P., Eschwège, É., Richard, J. L., Rosselin, G., & Claude, J. R. (1996) · Journal of Hypertension · doi:10.1097/00004872-199602000-00012 · Cited by 137
Bujalska, I. J., Shimojo, M., Howie, A., & Stewart, P. M. (1997) · Steroids · doi:10.1016/s0039-128x(96)00163-8 · Cited by 125
Ozols, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.5.2305 · Cited by 121
Horner, H. C., Munck, A., & Lienhard, G. E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45435-x · Cited by 119 · cited 1×
“The reduced insulin sensitivity appears to be mediated by GC antagonizing the insulin-stimulated translocation of glucose transporters from intracellular compartments to the plasma membrane [102-104].”
Stress‐Induced Cortisol Response and Fat Distribution in Women
Moyer, A. E., Rodin, J., Grilo, C. M., Cummings, N., Larson, L. M., & Rebuffé-Scrive, M. (1994) · Obesity Research · doi:10.1002/j.1550-8528.1994.tb00055.x · Cited by 118
Friedman, J. E., Sun, Y., Ishizuka, T., Farrell, C. J., McCormack, S. E., Herron, L. M., Hakimi, P., Lechner, P. S., & YUN, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31475 · Cited by 118
Fernández‐Real, J. M., PUGEAT, M. M., Grasa, M., Broch, M., Vendrell, J. J., Brun, J., & Ricart, W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011843 · Cited by 118
Friedman, J. E., Yun, J. S., Patel, Y. M., McGrane, M. M., & Hanson, R. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31478-9 · Cited by 117
Jamieson, A., Wallace, E. M., Andrew, R., Nunez, B. S., Walker, B. R., Fraser, R., White, P. C., & Connell, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6031 · Cited by 117
Davani, B., Khan, A., Hult, M., Mårtensson, E., Okret, S., Efendić, S., Jörnvall, H., & Oppermann, U. C. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000600200 · Cited by 116
Oral glucocorticoids and their complications
Gallant, C., & Kenny, P. (1986) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(86)70018-2 · Cited by 115
Diederich, S., Großmann, C., Hanke, B., Quinkler, M. O., Herrmann, M., Bähr, V., & Oelkers, W. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420200 · Cited by 115
Sex difference in the influence of obesity on the 24 hr mean plasma concentration of cortisol
Strain, G. W., Zumoff, B., Kream, J., Strain, J. J., Levin, J., & Fukushima, D. K. (1982) · Metabolism · doi:10.1016/0026-0495(82)90054-3 · Cited by 114
Torpy, D. J., Bachmann, A. W., Grice, J. E., Fitzgerald, S. P., Phillips, P. J. J., Whitworth, J. A., & Jackson, R. V. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7724 · Cited by 112
THE KIDNEY IS THE MAJOR SITE OF CORTISONE PRODUCTION IN MAN
Whitworth, J. A., Stewart, P. M., Burt, D., Atherden, S. M., & Edwards, C. R. W. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb01259.x · Cited by 109
Novel Human Corticosteroid-Binding Globulin Variant with Low Cortisol-Binding Affinity
Emptoz-Bonneton, A., Cousin, P., Seguchi, K., Avvakumov, G. V., Bully, C., Hammond, G. L., & PUGEAT, M. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6315 · Cited by 106
Cortisol and Its Relation to Insulin Resistance before and after Weight Loss in Obese Children
Reinehr, T., & Andler, W. (2004) · Hormone Research in Paediatrics · doi:10.1159/000079841 · Cited by 104
Corticosteroid Binding Globulin: A New Target for Cortisol-Driven Obesity
Ousova, O., Guyonnet‐Dupérat, V., Iannuccelli, N., Bidanel, J. P., Milan, D., Genêt, C., Llamas, B., Martine Yerle, B., Gellin, J., Chardon, P., et al. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0005 · Cited by 103
Zhang, X. K., Dong, J., & Chiu, J. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92969-8 · Cited by 101
Localization of 2 11β-OH Steroid Dehydrogenase Isoforms in Aortic Endothelial Cells
Brem, A. S., Bina, R. B., King, T. C., & Morris, D. J. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.459 · Cited by 99
Livingstone, D. E. W., & Walker, B. R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044842 · Cited by 99
Glucocorticoid inhibition of transcription from episomal proopiomelanocortin gene promoter.
Charron, J., & Drouin, J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.8903 · Cited by 98
Modulation of the Activity of Insulin-Dependent Enzymes of Lipogenesis by Glucocorticoids
Diamant, S., & Shafrir, E. (1975) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1975.tb04097.x · Cited by 97
Liu, Y., Nakagawa, Y., Wang, Y., Li, R., Li, X., Ohzeki, T., & Friedman, T. C. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1409 · Cited by 94
Draper, N. R., Echwald, S. M., Lavery, G. G., Walker, E. A., Fräser, R., Davies, E., Sørensen, T. I. A., Astrup, A. V., Adamski, J., Hewison, M., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011375 · Cited by 94
Diurnal Rhythm of Agouti-Related Protein and Its Relation to Corticosterone and Food Intake
Lu, X., Shieh, K.-R., Kabbaj, M., Barsh, G. S., Akil, H., & Watson, S. J. (2002) · Endocrinology · doi:10.1210/en.2002-220150 · Cited by 91
Glucocorticoids, Transmitters and Stress
Delbende, C., Delarue, C., Lefèbvre, H., Bunel, D. T., SZAFARCZYK, A., Mocaër, E., Kamoun, A., Jégou, S., & Vaudry, H. (1992) · The British Journal of Psychiatry · doi:10.1192/s0007125000296657 · Cited by 90
Reynolds, R. M., Walker, B. R., Syddall, H. E., Whorwood, C. B., Wood, P. J., & Phillips, D. I. W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7300 · Cited by 89
Acute severe steatohepatitis related to prednisolone therapy
Dourakis, S. P., Sevastianos, V., & Patsiaoura, K. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05644.x · Cited by 89
Justesen, J., Mosekilde, L., Holmes, M. C., Stenderup, K., Gasser, J. A., Mullins, J. J., Seckl, J. R., & Kassem, M. S. (2004) · Endocrinology · doi:10.1210/en.2003-1427 · Cited by 89
Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats
Livingstone, D., Kenyon, C., & Walker, B. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670533 · Cited by 88
Tomlinson, J., Draper, N., Mackie, J., Johnson, A. P., Holder, G., Wood, P. J., & Stewart, P. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8189 · Cited by 87
Bernier, J., Jobin, N., Emptoz-Bonneton, A., Pugeat, M. M., & Garrel, D. R. (1998) · Critical Care Medicine · doi:10.1097/00003246-199803000-00014 · Cited by 81
Adrenocortical activity in healthy children is associated with fat mass
Dimitriou, T., Maser‐Gluth, C., & Remer, T. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.3.731 · Cited by 80
The Endocrine Effects of Long-Term Treatment with Mifepristone (RU 486)
Lamberts, S. W. J., Koper, J. W., & de Jong, F. H. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-187 · Cited by 80
Adrenalectomy and Steroid Treatment in Obese (ob/ob) and Diabetic (db/db) Mice
Shimomura, Y., Bray, G. A., & Lee, M. (1987) · Hormone and Metabolic Research · doi:10.1055/s-2007-1011804 · Cited by 79
A new defect in the peripheral conversion of cortisone to cortisol
Phillipou, G., & Higgins, B. (1985) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(85)90451-0 · Cited by 79
A Weak TATA Box Is a Prerequisite for Glucocorticoid-dependent Repression of the Osteocalcin Gene
Meyer, T., Carlstedt‐Duke, J., & Starr, D. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30709 · Cited by 79
Schmoll, D., Allan, B. B., & Burchell, A. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00224-4 · Cited by 78 · cited 1×
“Examples of genes regulated by GR and involved in the hepatic gluconeogenesis, adipocyte differentiation, hormonal control, and inflammation are summarized in Table 1[39,42-66].”
Glucocorticoid metabolism and the Metabolic Syndrome: associations in an elderly cohort
Andrew, R., Galé, C. R., Walker, B. R., Seckl, J. R., & Martyn, C. N. (2002) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2002-34591 · Cited by 78
Liver-Selective Glucocorticoid Antagonists: A Novel Treatment for Type 2 Diabetes
von Geldern, T. W., Tu, N. P., Kym, P. R., Link, J. T., Jae, H.-S., Lai, C., Apelqvist, T., Rhonnstad, P., Hagberg, L., Koehler, K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0400045 · Cited by 74
11β-Hydroxysteroid dehydrogenase: unexpected connections
Walker, E. A., & Stewart, P. M. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00134-6 · Cited by 72
Identification and Partial Purification of “Transcortin”-like Protein within Human Lymphocytes
Werthamer, S., Samuels, A. J., & Amaral, L. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43460-1 · Cited by 72
Effect of insulin and glucocorticoids on glucose transporters in rat adipocytes
Carter-Su, C., & Okamoto, K. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.4.e441 · Cited by 71 · cited 1×
“The reduced insulin sensitivity appears to be mediated by GC antagonizing the insulin-stimulated translocation of glucose transporters from intracellular compartments to the plasma membrane [102-104].”
Hult, M., JÖRNVALL, H., & Oppermann, U. C. T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01515-4 · Cited by 68
Hollingdal, M., Juhl, C. B., Dall, R., Sturis, J., Veldhuis, J. D., Schmitz, O., & Pørksen, N. (2002) · Diabetologia · doi:10.1007/s125-002-8244-y · Cited by 67
Nonalcoholic fatty liver with alcoholic hyalin after long-term glucocorticoid therapy.
Itoh, S., Igarashi, M., Tsukada, Y., & Ichinoe, A. (1977) · PubMed · Cited by 66
Synthesis and Secretion of Corticosteroid-Binding Globulin by Rat Liver
Weiser, J. N., Do, Y.-S., & Feldman, D. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109323 · Cited by 65
Gelernter‐Yaniv, L., Feng, N., Sebring, N. G., Hochberg, Z., & Yanovski, J. A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802327 · Cited by 65
Zilberfarb, V., Siquier-Pernet, K., Strosberg, A. D., & Issad, T. (2001) · Diabetologia · doi:10.1007/s001250051630 · Cited by 65
Chatterjee, K., Madison, L. D., Mayo, S., & Jameson, J. L. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-1-100 · Cited by 65
Guillaume-Gentil, C., Assimacopoulos-Jeannet, F., & Jeanrenaud, B. (1993) · Diabetologia · doi:10.1007/bf02374470 · Cited by 62
Stress‐Induced Cortisol, Mood, and Fat Distribution in Men
Epel, E. S., Moyer, A. E., Martin, C. D., Macary, S. J., Cummings, N., Rodin, J., & Rebuffé-Scrive, M. (1999) · Obesity Research · doi:10.1002/j.1550-8528.1999.tb00385.x · Cited by 62
Modulation of triglyceride metabolism by glucocorticoids in diet-induced obesity
Mantha, L., Palacios, E., & Deshaies, Y. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.2.r455 · Cited by 62
Gender differences in the associations between cortisol and insulin in healthy subjects
Stolk, R. P., Lamberts, S. W. J., de Jong, F. H., Pols, H. A. P., & Grobbee, D. E. (1996) · Journal of Endocrinology · doi:10.1677/joe.0.1490313 · Cited by 61
Blood Pressure in Children and Adolescents with Cushing’s Syndrome before and after Surgical Cure
Magiakou, M., Mastorakos, G., Zachman, K., & Chrousos, G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3985 · Cited by 61
Metyrapone is a competitive inhibitor of 11β-hydroxysteroid dehydrogenase type 1 reductase
Sampathkumar, R., Yu, M., Khalil, M. W., & Yang, K. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00027-7 · Cited by 61
Wang, C., McLeod, R. S., Yao, Z., & Brindley, D. N. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1481 · Cited by 61
Subacute Severe Steatohepatitis During Prednisolone Therapy for Systemic Lupus Erythematosis
Nanki, T., Koike, R., & Miyasaka, N. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.03379.x · Cited by 58
Gruol, D. J., & Altschmied, J. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.1.8383286 · Cited by 58
Sutinen, J., Kannisto, K., Korsheninnikova, E., Nyman, T., Ehrenborg, E., Andrew, R., Wake, D. J., Hamsten, A., Walker, B. R., & Yki-J�rvinen, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1508-2 · Cited by 56
Glucocorticoid Metabolism and Adrenocortical Reactivity to ACTH in Myotonic Dystrophy
Johansson, Å., Andrew, R., Forsberg, H., Cederquist, K., Walker, B. R., & Olsson, T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7865 · Cited by 56
Immunocytochemical localization of corticosteroid-binding globulin in rat tissues
Kuhn, R. W., Green, A. L., RAYMOURE, W. J., & Siiteri, P. K. (1986) · Journal of Endocrinology · doi:10.1677/joe.0.1080031 · Cited by 54
RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism
Garrel, D. R., Moussalli, R., de Oliveira, A., Lesiège, D., & Larivière, F. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.2.7888013 · Cited by 53
Lin, B., MORRIS, D. W., & CHOU, J. Y. (1998) · DNA and Cell Biology · doi:10.1089/dna.1998.17.967 · Cited by 50
Effect of surgical treatment on hypertension in Cushing's syndrome.
Fallo, F., Sonino, N., Barzon, L., Pistorello, M., Pagotto, U., Paoletta, A., & Boscaro, M. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00299-5 · Cited by 48
Stauffer, A., Rochat, M. K., Dick, B., Frey, F. J., & Odermatt, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201556200 · Cited by 48
Plasma Cortisone Concentration as Measured by Radioimmunoassay
Srivastava, L., Werk, E. E., Thrasher, K., Sholiton, L. J., KOZERA, R., Nolten, W. E., & Knowles, H. C. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-5-937 · Cited by 47
Kim, P. J., Cole, M., Kalman, B. A., & Spencer, R. L. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00095-8 · Cited by 46
Vogeser, M., Felbinger, T. W., Kilger, E., Roell, W., Fraunberger, P., & Jacob, K. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00009-0 · Cited by 45
Adverse effects of corticosteroids.
Bialas, M. C., & Routledge, P. (1998) · PubMed · Cited by 44
Increased expression and activity of 11β-HSD-1 in diabetic islets and prevention with troglitazone
Duplomb, L., Lee, Y., Wang, M.-Y., Park, B. H., Takaishi, K., Agarwal, A. K., & Unger, R. H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.160 · Cited by 43
Self-citationEffects of licorice derivatives on vascular smooth muscle function
Brem, A. S., Bina, R. B., Hill, N. S., Alia, C., & Morris, D. J. (1996) · Life Sciences · doi:10.1016/s0024-3205(96)00617-0 · Cited by 42
Apparent Cortisone Reductase Deficiency: A Rare Cause of Hyperandrogenemia and Hypercortisolism
Biason‐Lauber, A., Suter, S. L., Shackleton, C. H. L., & ZACHMANN, M. (2000) · Hormone Research in Paediatrics · doi:10.1159/000023577 · Cited by 41
Olswang, Y., Blum, B., Cassuto, H., Cohen, H., Biberman, Y., Hanson, R. W., & Reshef, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300263200 · Cited by 39
Adverse effects of corticosteroids: II. systemic
Davis, G. F. (1986) · Clinics in Dermatology · doi:10.1016/0738-081x(86)90020-9 · Cited by 36
Oda, N., Nakai, A., Mokuno, T., Sawai, Y., Nishida, Y., Mano, T., Asano, K., Itoh, Y., Kotake, M., Kato, S., et al. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330121 · Cited by 33
Walker, B. R., Sang, K. S., Williams, B. C., & Edwards, C. R. W. (1994) · Journal of Hypertension · doi:10.1097/00004872-199401000-00006 · Cited by 28
Joyner, J. M., Hutley, L. J., Bachmann, A. W., Torpy, D. J., & Prins, J. B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00262.2002 · Cited by 26
Małunowicz, E., Romer, T. E., Urban, M. D., & Bossowski, A. T. (2003) · Hormone Research in Paediatrics · doi:10.1159/000069326 · Cited by 24
Effect of chenodeoxycholic acid on 11$beta;-hydroxysteroid dehydrogenase in various target tissues*1
Morris, D. J., Souness, G. W., Latif, S. A., Hardy, M. P., & Brem, A. S. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.027 · Cited by 23
Glucocorticoid induced expression of glutamine synthetase in hepatoma cells
Gaunitz, F., Heise, K., Schumann, R., & Gebhardt, R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02044-2 · Cited by 22
Reversal of steroid-induced insulin resistance by a nicotinic-acid derivative in man
Ekstrand, A., Saloranta, C., Ahonen, J. P., Grönhagen‐Riska, C., & Groop, L. (1992) · Metabolism · doi:10.1016/0026-0495(92)90306-u · Cited by 22
11β-Hydroxysteroid Dehydrogenase and Corticosteroid Action in Lyon Hypertensive Rats
Lloyd-MacGilp, S. A., Nelson, S. M., Florin, M., Lo, M., McKinnell, J., Sassard, J., & Kenyon, C. J. (1999) · Hypertension · doi:10.1161/01.hyp.34.5.1123 · Cited by 16
Aranoff, G. S., & Rosier, A. (1980) · European Journal of Endocrinology · doi:10.1530/acta.0.0940371 · Cited by 15
Corticosteroid and immune responses to cardiac surgery
Tinnikov, A. A., Legan, M. V., Sheveluk, N. A., Цветовская, Г. А., Naumenko, S. E., & Sg, S. (1996) · Steroids · doi:10.1016/0039-128x(96)00060-8 · Cited by 14
Ensler, K., Mohammadieh, M., Bröijersén, A., Angelin, B., & Gåfvels, M. E. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00118-x · Cited by 10
Grünfeld, C., & Jones, D. (1986) · Hormone and Metabolic Research · doi:10.1055/s-2007-1012257 · Cited by 6
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
The endocrine function of adipose tissue: an update
Ronti, T., Lupattelli, G., & Mannarino, E. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02474.x · Cited by 902
Reactive oxygen species in health and disease
Alfadda, A. A., & Sallam, R. M. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/936486 · Cited by 824
Complications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., De Martino, M. C., Newell-Price, J., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 641
Wetzel, S., Bon, R. S., Kumar, K., & Waldmann, H. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007004 · Cited by 505
Metadata
- Authors
- Wang, M.
- Venue
- Nutrition & Metabolism
- Published
- 2005-02-02
- Volume
- 2
- Issue
- 1
- Pages
- 3-3
- ISSN
- 1743-7075 (ISSN-L)
- OpenAlex
- W1610975395
- Cited by
- 277
- References
- 174
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.